ASSET PURCHASE AGREEMENT dated as of July 27, 2023 by and between AEGLEA BIOTHERAPEUTICS, INC. and IMMEDICA PHARMA ABAsset Purchase Agreement • August 11th, 2023 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • New York
ANTIBODY DISCOVERY AND OPTION AGREEMENTAntibody Discovery and Option Agreement • August 11th, 2023 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Antibody Discovery and Option Agreement (“Agreement”) is entered into and effective as of May 25, 2023 (the “Effective Date”), by and among Paragon Therapeutics, Inc., a Delaware corporation (“Paragon”), Parapyre Holding LLC, a Delaware limited liability company (“Parapyre”) and Spyre Therapeutics, Inc. (“Spyre”), a Delaware corporation. Paragon, Parapyre and Spyre are also referred to herein individually as a “Party”, or collectively as the “Parties.”
June 22, 2023 Cameron Turtle Re: Offer of Employment Dear Cameron:Aeglea BioTherapeutics, Inc. • August 11th, 2023 • Pharmaceutical preparations
On behalf of Aeglea BioTherapeutics, Inc. (the “Company”), I am very pleased to offer you a position as Chief Operating Officer of the Company (the “Role”) pursuant to this letter agreement (the “Agreement”), provided you accept such offer as indicated by your signature below.
